Authorized Generic Pricing: Why They Cost Less Than Brand Name Drugs

Authorized Generic Pricing: Why They Cost Less Than Brand Name Drugs

When you walk into a pharmacy and see two identical pills side by side-one labeled with a big brand name, the other with a simple generic label-why does the generic cost so much less? If they’re the same drug, why isn’t the price the same? The answer isn’t just about generic drugs. It’s about authorized generics.

What Exactly Is an Authorized Generic?

An authorized generic is the exact same medicine as the brand-name drug. Same active ingredient. Same capsule, tablet, or injection. Same factory. Same quality control. The only difference? The label. It doesn’t say "Lipitor" or "Viagra." It says something like "atorvastatin" or "sildenafil." But here’s the twist: it’s made by the original brand company-or licensed to another company with the brand company’s permission.

The U.S. Food and Drug Administration (FDA) keeps a public list of these. As of October 2023, there were 137 active authorized generics on the list. These aren’t knockoffs. They’re the real thing, just sold under a different name. That’s why they’re called "authorized." The brand company approves it. The FDA monitors it. And because they use the same New Drug Application (NDA) as the brand, they skip the usual generic approval process. No extra testing. No delays.

Why Do Authorized Generics Cost Less?

The short answer: no marketing. No patents. No brand loyalty. But there’s more to it.

Brand-name drugs come with a huge price tag because the company spent years and billions developing the drug, running clinical trials, and advertising. Once the patent expires, other companies can make copies. But here’s where it gets interesting. The original brand company doesn’t just sit back and watch their sales vanish. Many launch their own authorized generic at the same time as the first generic competitor.

Why? To stay in the game.

When a brand company releases an authorized generic, they’re not giving up-they’re competing. They know that if they don’t, the first generic maker will charge a high price during their 180-day exclusivity window. That’s a rule from the 1984 Hatch-Waxman Act. It gives the first generic company a head start with no competition. But if the brand company drops its own version at the same time, that first generic can’t charge top dollar anymore. They have to slash prices to stay competitive.

The result? Retail prices for the drug drop 4% to 8% compared to when no authorized generic is present. For pharmacies buying in bulk, the discount is even bigger-up to 18% lower than if the brand had no competition at all. That’s not just savings for insurers. That’s savings for you at the counter.

Authorized Generics vs. Regular Generics

Not all generics are the same. Here’s how they differ:

  • Regular generics: Made by a different company after the patent expires. They go through a separate FDA approval process called an Abbreviated New Drug Application (ANDA). They’re cheaper than the brand, but not always as cheap as an authorized generic.
  • Authorized generics: Made by the brand company or under its license. Same factory, same formula, same packaging (except the name). No ANDA needed. They enter the market on day one of generic competition and immediately push prices down.
Think of it like this: if you bought a Coca-Cola and then saw a bottle with the exact same taste, same ingredients, same bottle-but labeled "Cola Classic"-and it cost half as much, you’d probably grab it. That’s what an authorized generic is. It’s the same drink, just a different label.

Same production line in a factory, two pill batches labeled differently, corporate figure watching above.

How Authorized Generics Change the Market

Before authorized generics, the first generic company had a free pass. They could set a high price, knowing no one else could compete for six months. That meant patients paid more, insurers paid more, and Medicare paid more.

Now? The moment a brand’s patent expires, you might see three versions on the shelf:

  • The original brand-name drug
  • An authorized generic
  • A regular generic from another company
That’s a three-way race. And the brand company doesn’t want to lose its customers. So they price the authorized generic just below the brand. The regular generic has to follow. Suddenly, instead of paying $150 for a 30-day supply of a brand drug, you might pay $110 for the authorized version or $95 for the regular generic.

Medicaid data shows that when an authorized generic enters the market, on-invoice prices paid by pharmacies drop by 13% to 18%. That’s not a small bump. That’s a major shift.

Real Examples: When Authorized Generics Made a Difference

In 2016, Mylan faced backlash for raising the price of the EpiPen from $100 to $600. Then they released an authorized generic for $300. That wasn’t charity. It was damage control. But it also gave people a real, affordable option.

Gilead did something similar with its hepatitis C drugs Harvoni and Epclusa. Before their patents expired, they launched authorized generics to keep market share as cheaper alternatives loomed. They didn’t wait for competition to hit-they started it themselves.

And it worked. In both cases, patients got lower prices. Pharmacies got better margins. And the brand companies still made money-just not as much as they hoped.

Why Your Pharmacy Might Not Tell You About Them

Here’s the catch: authorized generics aren’t always easy to find.

Pharmacy Benefit Managers (PBMs)-the middlemen between insurers and pharmacies-decide which drugs get placed on which tiers. Sometimes, they put the brand-name drug and the authorized generic on the same tier. That means your copay is the same for both. You might not even know you’re paying the same price for the exact same drug.

But if the PBM puts the authorized generic on a lower tier, you save. A 2022 analysis of 1.2 million Medicare Part D patients showed that when AGs were placed on the same tier as regular generics, medication adherence went up by 8.2 percentage points. People took their meds more consistently because they could afford them.

The problem? PBMs don’t always make that choice. Some still favor the brand. Others hide the authorized generic behind complex pricing rules called Maximum Allowable Cost (MAC) lists. These lists set the max a plan will pay for a drug. But they’re often opaque. Thirty-two states now require PBMs to disclose how they set these prices. Still, it’s not universal.

Patient holding three pill bottles with price tags, pharmacist pointing to authorized generic as safe choice.

Are Authorized Generics Safe?

Absolutely. The FDA requires them to meet the same standards as the brand. Same manufacturing facility. Same quality checks. Same batch testing. There’s no difference in safety or effectiveness.

Dr. Aaron Kesselheim from Harvard Medical School says authorized generics "compel all market participants to adjust their pricing strategies from day one." That’s good for patients. It stops the "monopoly pricing" that happens when only one generic is allowed to compete.

Some critics worry that brand companies use authorized generics as a way to delay real competition. The Federal Trade Commission has looked into this. In some cases, brand companies have paid generic makers to delay launching their own version-and then launched their own authorized generic instead. That’s called a "pay-for-delay" deal. It’s controversial. And the FTC is cracking down.

But that doesn’t mean authorized generics themselves are bad. It means the system can be gamed. The drug itself? Still safe. Still effective. Still cheaper.

What This Means for You

If you’re on a brand-name drug, ask your pharmacist: "Is there an authorized generic for this?" Don’t assume the generic you’re given is the cheapest option. Sometimes, the authorized version is cheaper than the regular generic.

Check your formulary. If your insurance plan puts the brand and the authorized generic on the same tier, you’re not saving money. Ask your plan to move the authorized generic to a lower tier.

And if you’re paying cash? Always compare the price of the brand, the regular generic, and the authorized generic. The difference can be $20, $50, even $100 a month.

In 2023, the Inflation Reduction Act capped out-of-pocket drug costs for Medicare beneficiaries at $2,000 a year. Authorized generics play a big role in making that cap possible. They’re not just a corporate tactic. They’re a tool for affordability.

The Bigger Picture

Authorized generics make up about 12% of the $60 billion U.S. generic drug market. That’s not huge-but their impact is huge. They force competition. They lower prices. They help people stick to their prescriptions.

They’re not perfect. The system still has loopholes. PBMs still have too much power. But when it comes to getting the same medicine for less, authorized generics are one of the most reliable tools we have.

The next time you pick up a prescription, don’t just look at the name on the bottle. Ask what’s underneath it. You might be paying more than you need to-for a drug that’s already been made, tested, and approved.

Are authorized generics the same as brand-name drugs?

Yes. Authorized generics are identical to their brand-name counterparts in dosage, strength, safety, quality, and how they work. They’re made in the same factory, using the same ingredients and processes. The only difference is the label and the price.

Why are authorized generics cheaper than brand-name drugs?

They don’t carry the marketing, advertising, and patent recovery costs that brand-name drugs do. Since they’re made by the original manufacturer or under its license, they skip the lengthy FDA approval process for generics. That cuts costs, and those savings get passed on.

Can I trust the quality of an authorized generic?

Yes. The FDA requires authorized generics to meet the same strict standards as brand-name drugs. They’re held to the same manufacturing and quality controls. There’s no difference in safety or effectiveness.

Why doesn’t my pharmacy always offer the authorized generic?

Pharmacy Benefit Managers (PBMs) decide which drugs go on which insurance tiers. Sometimes, they place the brand and the authorized generic on the same tier, so your copay is the same. Other times, they don’t promote the authorized version at all. Always ask your pharmacist or check your plan’s formulary.

Do authorized generics delay cheaper generic competition?

In some cases, yes. There have been instances where brand companies used authorized generics as part of "pay-for-delay" deals to block other generics from entering. The FTC is actively investigating these practices. But the authorized generic itself isn’t the problem-it’s how it’s used in some corporate strategies.

How can I find out if an authorized generic exists for my drug?

Ask your pharmacist directly. You can also check the FDA’s quarterly list of authorized generics online. Many pharmacy apps and insurance portals now show if an authorized generic is available and how it compares in price to the brand and other generics.

Kiera Masterson
Kiera Masterson

I am a pharmaceutical specialist with a passion for making complex medical information accessible. I focus on new drug developments and enjoy sharing insights on improving health outcomes. Writing allows me to bridge the gap between research and daily life. My mission is to help readers make informed decisions about their health.

1 Comments

  • Emma #########
    Emma ######### January 17, 2026

    So basically, if I’m paying $120 for Lipitor, and there’s an authorized generic for $45, why does my pharmacy still push the brand? I’ve asked. They say it’s ‘on my tier.’ But my tier is the same for both. Smells like a PBM scam to me.

Write a comment